Posts by: Catarina Silva, MSc

Catarina Silva, MSc

With over three years of experience in the medical communications business, Catarina holds a BSc. in Biomedical Sciences and a MSc. in Neurosciences. Apart from writing, she has been involved in patient-oriented translational and clinical research.

March 16, 2018March 16, 2018

Protalix Alleviates Ulcerative Colitis, Sending Some Cases Into Remission, Phase 2 Trial Shows

News

Protalix BioTherapeutics’ OPRX-106 alleviated ulcerative colitis and in some cases sent it into remission, a Phase 2 clinical trial shows . OPRX-106 is a TNF inhibitor that Protalix scientists grew from ... Read more

March 8, 2018

Heart Attack Risk Significantly Higher in Young Adult IBD Patients, Research Suggests

News

Young adults with inflammatory bowel disease (IBD) are at greater risk of having a heart attack. Because of that, IBD should be considered an independent risk factor for heart disease. ... Read more

January 3, 2018

Study on Protein Receptor’s Role in IBD Supports Decision to Develop Blocking Therapy, OSE Says

News

A study that OSE Immunotherapeutics conducted on the role that a protein receptor plays in bowel disease supports its development of a treatment that blocks the receptor, the company reports. It designed OSE-127 ... Read more

November 29, 2017November 29, 2017

Older IBD Patients More Likely to Need Surgery and Given Cortisone Treatments Than Younger Ones, Swedish Study Reports

News

Older adults, age 60 or older, with inflammatory bowel disease (IBD) in Sweden are often treated with cortisone medications instead of newer, immune system-targeting therapies, and they are likely to ... Read more

November 21, 2017

First Patient Enrolls in Phase 2 Trial of ABX464, Potential Ulcerative Colitis Treatment

News

A first patient has been enrolled in a proof-of-concept clinical trial of ABX464 as a possible treatment for people with moderate-to-severe active ulcerative colitis, its developer, Abivax, announced in a press release. The patient ... Read more